Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenhui Luo

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Acta Pharmaceutica Sinica. B|May 15, 2025
eIF3a function in immunity and protection against severe sepsis by regulating B cell quantity and function through m<sup>6</sup>A modificationQianying Ouyang, Jiajia Cui, Yang Wang, et al.
International Journal of Cancer|February 24, 2018
Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) studyZimin Sun, Huilan Liu, Chenhui Luo, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Acta Pharmaceutica Sinica. B|May 15, 2025
eIF3a function in immunity and protection against severe sepsis by regulating B cell quantity and function through m<sup>6</sup>A modificationQianying Ouyang, Jiajia Cui, Yang Wang, et al.
International Journal of Cancer|February 24, 2018
Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) studyZimin Sun, Huilan Liu, Chenhui Luo, et al.
Pageof 2